Commentary from across the Golden Triangle: Cambridge, Oxford and London

On Cambridge, Charlie Fletcher, Partner in the Corporate team, commented:

Cambridge maintained its reputation as a globally renowned hub for innovation. This year Health and Medtech attracted significant investment, hosting half of our wider Health and Medtech deals. The city's strong academic foundations, entrepreneurial community and talent pool continue to support a thriving ecosystem for life sciences and technology.

Speaking on Oxford, Nicola McConville, Partner in the Corporate team, commented:

Oxford's diverse sector engagement is evident, with a balanced distribution of deals across Life Science, Deeptech, Cleantech, and other emerging sectors. The city's rich academic and research environment fosters a conducive atmosphere for growth and investment.

Hayley Cross, Partner in the Corporate team, commented on the landscape in London, saying:

London continues to be exciting and remains at the heart of venture capital in the UK. We completed 89 deals in London across all the key sectors in venture, highlighting its status as a versatile and attractive location for investors. Support for venture-backed businesses is at its best in London. With access to networking events, communities, conferences and accelerators, together with its connection to the rest of Europe, the US and beyond emerging companies in London continue to draw significant capital, particularly in Digital, Technology and AI.